Plain-English translation of NCT05389787 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS) — a non-invasive procedure that uses magnetic pulses to stimulate a specific part of your brain called the cerebellum. Researchers believe this treatment might help improve cognitive functions (like memory and concentration) and overall brain activity in people with schizophrenia. The study will compare people who receive the active treatment alongside standard care with people who receive a placebo (fake) treatment alongside standard care.
Current treatments for schizophrenia don't always fully address cognitive problems like difficulty concentrating or remembering things. This trial is exploring whether stimulating the cerebellum with magnetic pulses could offer an additional benefit beyond standard medications and therapy.
You likely qualify if…
You likely don't qualify if…
You will come to the study clinic five days a week for four weeks to receive TMS treatment sessions. During your participation, you'll undergo brain imaging scans (fMRI), answer questions about your symptoms and thinking abilities, and take cognitive tests at the start, after two weeks, and after four weeks. Half of participants will receive active TMS treatment while the other half receive a placebo procedure, but everyone continues their regular schizophrenia medications and care.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States